See more : Avadh Sugar & Energy Limited (AVADHSUGAR.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Bafna Pharmaceuticals Limited (BAFNAPH.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Bafna Pharmaceuticals Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- PCC Rokita SA (PCR.WA) Income Statement Analysis – Financial Results
- Shivansh Finserve Limited (SHIVA.BO) Income Statement Analysis – Financial Results
- PT Surya Fajar Capital Tbk (SFAN.JK) Income Statement Analysis – Financial Results
- C HIGHPRECISION (0591.HK) Income Statement Analysis – Financial Results
- Photocure ASA (PHO.OL) Income Statement Analysis – Financial Results
Bafna Pharmaceuticals Limited (BAFNAPH.NS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.bafnapharma.com
About Bafna Pharmaceuticals Limited
Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. The company provides delayed and sustained release, chewable, and orally disintegrating tablets. It also exports its products. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.52B | 1.15B | 851.40M | 712.18M | 424.73M | 433.59M | 471.71M | 649.62M | 853.18M | 976.75M | 1.85B | 1.76B | 1.26B | 1.02B | 751.81M | 472.54M | 396.07M | 372.46M |
| Cost of Revenue | 1.07B | 765.94M | 512.86M | 454.56M | 270.24M | 345.69M | 438.92M | 577.74M | 729.17M | 916.63M | 1.36B | 1.33B | 980.35M | 859.88M | 629.74M | 356.96M | 367.40M | 351.76M |
| Gross Profit | 455.59M | 387.56M | 338.55M | 257.62M | 154.49M | 87.90M | 32.79M | 71.88M | 124.01M | 60.12M | 497.51M | 428.60M | 276.27M | 159.36M | 122.07M | 115.58M | 28.67M | 20.71M |
| Gross Profit Ratio | 29.88% | 33.60% | 39.76% | 36.17% | 36.37% | 20.27% | 6.95% | 11.06% | 14.54% | 6.16% | 26.84% | 24.38% | 21.99% | 15.63% | 16.24% | 24.46% | 7.24% | 5.56% |
| Research & Development | 15.36M | 7.21M | 14.73M | 13.59M | 10.10M | 7.53M | 3.71M | 7.19M | 8.17M | 9.56M | 11.63M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 193.12M | 14.80M | 15.81M | 7.22M | 12.12M | 5.47M | 7.83M | 4.45M | 29.19M | 111.23M | 15.08M | 21.96M | 0.00 | 20.38M | 13.61M | 9.50M | 5.39M | 4.99M |
| Selling & Marketing | 6.01M | 5.63M | 23.42M | 6.48M | 3.68M | 8.10M | 4.75M | 7.94M | 791.39K | 17.24M | 49.32M | 36.91M | 0.00 | 11.52M | 7.36M | 4.98M | 3.18M | 4.02M |
| SG&A | 199.13M | 20.43M | 39.23M | 13.70M | 15.79M | 13.57M | 12.58M | 12.39M | 29.98M | 128.47M | 243.53M | 198.35M | 0.00 | 31.90M | 20.97M | 14.49M | 8.56M | 9.01M |
| Other Expenses | 0.00 | 32.73M | 12.61M | 74.00K | 75.00K | 4.08M | 7.57M | 52.75K | 55.20K | 55.20K | 344.07M | 120.00K | 83.20M | 40.10M | 22.83M | 19.23M | 5.67M | 4.50M |
| Operating Expenses | 214.49M | 283.75M | 274.20M | 196.24M | 174.10M | 159.14M | 160.87M | 164.77M | 153.07M | 251.61M | 344.07M | 283.68M | 138.04M | 61.13M | 53.69M | 63.64M | 9.86M | 3.72M |
| Cost & Expenses | 1.29B | 1.05B | 787.06M | 650.80M | 444.33M | 504.83M | 599.79M | 742.50M | 882.24M | 1.17B | 1.70B | 1.61B | 1.12B | 921.02M | 683.43M | 420.60M | 377.26M | 355.47M |
| Interest Income | 1.25M | 445.00K | 446.00K | 395.00K | 394.00K | 1.17M | 285.00K | 1.86M | 3.88M | 3.69M | 3.60M | 3.93M | 3.24M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 22.90M | 20.38M | 5.24M | 886.00K | 10.00K | 19.68M | 67.35M | 110.49M | 112.89M | 124.48M | 132.14M | 119.13M | 83.20M | 42.96M | 23.19M | 20.61M | 5.67M | 5.08M |
| Depreciation & Amortization | 49.95M | 53.34M | 54.93M | 44.78M | 32.67M | 34.76M | 39.74M | 42.20M | 48.59M | 59.85M | 89.94M | 82.50M | 63.03M | 22.66M | 17.38M | 13.72M | 3.46M | 3.68M |
| EBITDA | 146.34M | 189.88M | 115.03M | 106.24M | 13.90M | -126.90M | -38.00M | -50.94M | 14.26M | -128.68M | 246.99M | 245.17M | 189.02M | 120.89M | 80.22M | 59.08M | 22.10M | 19.94M |
| EBITDA Ratio | 9.60% | 16.46% | 15.65% | 14.59% | 3.32% | -7.57% | -17.44% | -7.55% | 1.00% | -14.13% | 13.13% | 12.86% | 16.02% | 11.58% | 11.36% | 13.60% | 5.62% | 5.40% |
| Operating Income | 237.66M | 117.72M | 66.41M | 61.46M | -19.75M | -162.82M | -128.08M | -203.63M | -153.19M | 60.67M | 24.91M | 54.92M | 138.23M | 98.23M | 68.38M | 51.94M | 18.81M | 16.99M |
| Operating Income Ratio | 15.59% | 10.21% | 7.80% | 8.63% | -4.65% | -37.55% | -27.15% | -31.35% | -17.96% | 6.21% | 1.34% | 3.12% | 11.00% | 9.64% | 9.10% | 10.99% | 4.75% | 4.56% |
| Total Other Income/Expenses | -164.18M | -82.63M | -12.82M | -279.00K | -52.76M | -114.37M | -106.42M | -105.63M | -203.76M | 100.09M | -135.90M | -93.10M | -84.52M | -45.82M | -28.73M | -27.19M | -5.83M | -5.82M |
| Income Before Tax | 73.48M | 116.16M | 73.08M | 58.27M | -18.83M | -182.93M | -147.17M | -203.63M | -153.19M | 60.67M | 24.91M | 54.92M | 53.71M | 47.38M | 39.65M | 24.75M | 12.98M | 11.17M |
| Income Before Tax Ratio | 4.82% | 10.07% | 8.58% | 8.18% | -4.43% | -42.19% | -31.20% | -31.35% | -17.96% | 6.21% | 1.34% | 3.12% | 4.27% | 4.65% | 5.27% | 5.24% | 3.28% | 3.00% |
| Income Tax Expense | 0.00 | 2.78M | 12.56M | -2.30M | 229.71M | 10.67M | 21.93M | -9.03M | -1.78M | -1.53M | 10.47M | 14.79M | 34.66M | 13.90M | 14.84M | 14.08M | 992.14K | 1.49M |
| Net Income | 73.48M | 113.38M | 52.16M | 58.27M | -247.29M | -188.70M | -167.37M | -190.87M | -140.27M | 61.77M | 14.04M | 39.63M | 18.41M | 33.48M | 24.81M | 10.68M | 11.98M | 9.68M |
| Net Income Ratio | 4.82% | 9.83% | 6.13% | 8.18% | -58.22% | -43.52% | -35.48% | -29.38% | -16.44% | 6.32% | 0.76% | 2.25% | 1.46% | 3.28% | 3.30% | 2.26% | 3.03% | 2.60% |
| EPS | 3.11 | 4.79 | 2.21 | 2.46 | -104.54 | -7.98 | -9.24 | -10.43 | -8.80 | 3.28 | 0.75 | 2.14 | 1.04 | 1.92 | 1.55 | 0.74 | 1.52 | 2.51 |
| EPS Diluted | 3.11 | 4.79 | 2.21 | 2.46 | -104.54 | -7.98 | -9.24 | -10.43 | -8.80 | 3.28 | 0.75 | 2.14 | 1.04 | 1.92 | 1.55 | 0.74 | 1.52 | 2.51 |
| Weighted Avg Shares Out | 23.63M | 23.66M | 23.66M | 23.66M | 2.37M | 23.66M | 18.11M | 18.30M | 15.94M | 18.83M | 18.71M | 18.52M | 17.70M | 17.44M | 15.98M | 14.38M | 7.88M | 3.87M |
| Weighted Avg Shares Out (Dil) | 23.66M | 23.66M | 23.66M | 23.66M | 2.37M | 23.66M | 18.11M | 18.30M | 15.94M | 18.83M | 18.71M | 18.52M | 17.70M | 17.44M | 15.98M | 14.38M | 7.88M | 3.87M |
No news found for: BAFNAPH.NS
Source: https://incomestatements.info
Category: Stock Reports